John Murphy, CEO The COVID-Long haul Foundation Abstract Since the emergence of SARS-CoV-2 in 2019, research has increasingly demonstrated that COVID-19 is a multisystem disease with significant ophthalmologic implications. While […]
Long COVID and Optic Nerve Involvement: Pathobiology, Clinical Manifestations, and Management
John Murphy, M.D., M.P.H. D.P.H., President Covid Long-haul Foundation Abstract Post‑acute sequelae of SARS‑CoV‑2 infection (long COVID) frequently manifest with systemic, neurologic, and visual symptoms. While neurocognitive and cardiopulmonary sequelae […]
Immune-Related Peripheral Keratopathy in Post-COVID-19 Syndrome
Chen B, Li X, Qu L, Wu S, DOI https://doi.org/10.2147/IMCRJ.S539734 Background: Post-COVID-19 Syndrome, marked by systemic immune dysregulation, has been linked to various ocular manifestations, including conjunctivitis, anterior uveitis, and vitritis. Emerging evidence highlights the […]
COVID-19 and Cataractogenesis: Mechanistic Insights into Viral-Induced Ocular Pathology
Abstract Cataracts, the leading cause of blindness worldwide, are traditionally associated with aging, oxidative stress, and metabolic disorders. However, emerging evidence suggests that SARS-CoV-2 infection may accelerate or precipitate cataract […]
5 years later, long Covid is still a medical mystery: What scientists have learned
By Katie Camero, NBC News Why do some people develop disabling chronic conditions after the initial viral infection? The struggles of living with long Covid five years after the start of […]
Ocular Symptoms Among COVID-19 Positive Patients: A Cross-Sectional Survey
Nayef F. Alswaina • Abdulrahman Alsowinea • Yazeed K. Alhabeeb •et. al. DOI: 10.7759/cureus.76671 Abstract Background Coronavirus disease (COVID-19), a widespread viral illness, has been linked to a range of respiratory and other systemic symptoms. Along […]
Non-invasive brain microcurrent stimulation therapy of long-COVID-19 reduces vascular dysregulation and improves visual and cognitive impairment
Bernhard A Sabel a,*, Wanshu Zhou a, Frank Huber a, et. al., PMCID: PMC8764598 PMID: 34924406 Abstract Background: An effective treatment is needed for long-COVID patients which suffer from symptoms of vision and/or cognition impairment such as impaired […]
Endogenous Endophthalmitis Associated With COVID-19: A Systematic Review on Its Incidence, Risk Factors, Causative Organisms, and Prognosis
Abdulaziz M. Alshehri, DOI: 10.7759/cureus.70523 Cureus 16(9): e70523. doi:10.7759/cureus.70523 Abstract Endogenous endophthalmitis (EE) is a rare but severe intraocular infection resulting from hematogenous dissemination of microorganisms. During the COVID-19 pandemic, there has […]
A GABA-receptor agonist reduces pneumonitis severity, viral load, and death rate in SARS-CoV-2-infected mice
Jide Tian1*Barbara J. Dillion2Jill Henley3et. al. Gamma-aminobutyric acid (GABA) and GABA-receptors (GABA-Rs) form a major neurotransmitter system in the brain. GABA-Rs are also expressed by 1) cells of the innate […]
Acute Macular Neuroretinopathy Following COVID-19 Infection: A Case Report
Ryan Zubricky • William Ensor, DOI: 10.7759/cureus.78182 Abstract A 24-year-old female presented with a new scotoma in her left eye one week after testing positive for COVID-19. Fundoscopy revealed an inferonasal perifoveal retinal […]